Sugi Predict

Sugi Predict / Compounds / SCHEMBL2931035

SCHEMBL2931035

SCHEMBL2931035

CCN(CC)CCNC(=O)c1ccc(Nc2cncc(-c3cc4ccccc4[nH]3)n2)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ KDR P35968 1/20 0.40
▸ KMT2A Q03164 1/20 0.38
▸ MCHR1 Q99705 5/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ CDK2 P24941 2/20 0.38
▸ EGFR P00533 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ RAD52 P43351 2/20 0.37
▸ UBE2N P61088 1/20 0.37
▸ BRAF P15056 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ RXFP1 Q9HBX9 1/20 0.37
▸ GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2935067 0.95 L3MBTL1 (0.40) L3MBTL1KDM4EALDH1A1SMN1; SMN2KDR
SCHEMBL2931626 0.82 BRAF (0.39) KDRCDK2BRAF
SCHEMBL2935070 0.81 BRAF (0.34) KDRBRAF
SCHEMBL2931747 0.78 TMEM97 (0.45) KMT2AMCHR1HTR2CCDK2BRAF
Trifluoroacetic Acid SCHEMBL2931064 0.75 TMEM97 (0.41) ALDH1A1SMN1; SMN2MCHR1HTR2CHPGD
SCHEMBL2928708 0.73 BRAF (0.39) KDRCDK2BRAF
SCHEMBL2931629 0.72 MAPT (0.40) L3MBTL1KDM4EALDH1A1KDRKMT2A
SCHEMBL2933256 0.72 BRAF (0.57) BRAF
SCHEMBL2930653 0.71 TMEM97 (0.43) L3MBTL1MCHR1HTR2CCDK2TP53
SCHEMBL2932836 0.71 ITK (0.41) SMN1; SMN2KDREGFRBRAFNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044051-B1 PYRIDINE AND PYRAZINE DERIVATIVES AS MNK KINASE INHIBITORS BIOVITRUM AB PUBL (SE) 2010-01-27 — — EP claimed
CN-101472912-A Pyridine and pyrazine derivatives as MNK kinase inhibitors BIOVITRUM AB PUBL (SE) 2009-07-01 — — CN claimed
EP-2044051-A1 PYRIDINE AND PYRAZINE DERIVATIVES AS MNK KINASE INHIBITORS BIOVITRUM AB (publ) (SE) 2009-04-08 — — EP claimed
US-20080039450-A1 Compounds BIOVITRUM AB (PUBL.) (SE) 2008-02-14 — — US claimed
WO-2007147874-A1 PYRIDINE AND PYRAZINE DERIVATIVES AS MNK KINASE INHIBITORS BIOVITRUM AB (PUBL) (SE) 2007-12-27 — — WO claimed
EP-2044051-B1 PYRIDINE AND PYRAZINE DERIVATIVES AS MNK KINASE INHIBITORS BIOVITRUM AB PUBL (SE) 2010-01-27 — — EP disclosed
US-20080039450-A1 Compounds BIOVITRUM AB (PUBL.) (SE) 2008-02-14 — — US disclosed
US-20080039450-A1 Compounds BIOVITRUM AB (PUBL.) (SE) 2008-02-14 — — US disclosed
WO-2007147874-A1 PYRIDINE AND PYRAZINE DERIVATIVES AS MNK KINASE INHIBITORS BIOVITRUM AB (PUBL) (SE) 2007-12-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039450-A1 Compounds NEK2, CSNK2A3, CSNK2A1 L3MBTL1 3556/4885KDM4E 2380/4885ALDH1A1 3748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.